drugset

drugset / Trial / NCT01209741

Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)

NCT01209741 ↗

Phase 1 Completed 48 enrolled Merck Sharp & Dohme LLC

RandomizedCrossoverOpen-labelTreatment

Summary

This study will evaluate the comparative bioavailability of three capsule formulations of MK-0974.

Timeline

Start: 2007-10
Primary completion: 2007-11
Completion: 2007-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Telcagepant	Small molecule	300 mg	Oral

Indications